Literature DB >> 7014450

Properties of a hemolysin produced by group B streptococci.

B A Marchlewicz, J L Duncan.   

Abstract

A hemolysin that appears to be responsible for the zones of beta-hemolysis surrounding colonies of group B streptococci (Streptococcus agalactiae) on blood agar plates has been isolated and partially purified. No soluble hemolysin was detectable in the supernatants of streptococcal cultures grown in several types of media. However, hemolytic activity was detected when streptococci were incubated with erythrocytes, and soluble hemolysin was isolated when bacterial suspensions were incubated in the presence of a variety of agents, including calf serum, albumin, Tween 80, and starch. Glucose and other fermentable carbohydrates stimulated hemolysin production, and metabolic inhibitors greatly reduced the titer of hemolysin that could be recovered, suggesting that cellular metabolism is necessary for hemolysin production or release. The soluble hemolysin was concentrated by ammonium sulfate precipitation and partially purified by gel filtration. Agents known to inhibit other streptococcal hemolysins, including phospholipids, trypan blue, proteases, and cholesterol, were tested for their effect on the group B hemolysin. Only the phospholipids inhibited hemolysin activity. The group B streptococcal hemolysin appears to be similar to, but distinct from, streptolysin S produced by Streptococcus pyogenes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7014450      PMCID: PMC551387          DOI: 10.1128/iai.30.3.805-813.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Formation of a bacterial toxin (streptolysin S) by resting cells.

Authors:  A W BERNHEIMER
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

2.  Microcapsule of type III strains of group B Streptococcus: production and morphology.

Authors:  C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

3.  Electron microscopic definition of surface antigens of group B Streptococcus.

Authors:  D L Kasper; C J Baker
Journal:  J Infect Dis       Date:  1979-02       Impact factor: 5.226

Review 4.  The emergence of group B streptococci in infections of the newborn infant.

Authors:  B F Anthony; D M Okada
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

Review 5.  Summary of the workshop on perinatal infections due to group B Streptococcus.

Authors: 
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

6.  Streptolysin S: improved purification and characterization.

Authors:  C Y Lai; M T Wang; J B de Faria; T Akao
Journal:  Arch Biochem Biophys       Date:  1978-12       Impact factor: 4.013

7.  Physical behavior of streptolysin S.

Authors:  A W Bernheimer
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490

8.  Nature and mechanism of action of the CAMP protein of group B streptococci.

Authors:  A W Bernheimer; R Linder; L S Avigad
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  Chicken embryo model for type III group B beta-hemolytic streptococcal septicemia.

Authors:  J Tieffenberg; L Vogel; R R Kretschmer; D Padnos; S P Gotoff
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

10.  Immunodeterminant specificity of human immunity to type III group B streptococcus.

Authors:  D L Kasper; C J Baker; R S Baltimore; J H Crabb; G Schiffman; H J Jennings
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  24 in total

1.  Identification and partial characterization of a cytolytic toxin produced by Gardnerella vaginalis.

Authors:  G Rottini; A Dobrina; O Forgiarini; E Nardon; G A Amirante; P Patriarca
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells.

Authors:  N Charland; V Nizet; C E Rubens; K S Kim; S Lacouture; M Gottschalk
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis.

Authors:  J N Weiser; C E Rubens
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

4.  Inactivation of the alpha C protein antigen gene, bca, by a novel shuttle/suicide vector results in attenuation of virulence and immunity in group B Streptococcus.

Authors:  J Li; D L Kasper; F M Ausubel; B Rosner; J L Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Transport of multidrug resistance substrates by the Streptococcus agalactiae hemolysin transporter.

Authors:  Birgit Gottschalk; Gerd Bröker; Melanie Kuhn; Simone Aymanns; Ute Gleich-Theurer; Barbara Spellerberg
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

6.  Biochemical markers of the penicillin-induced L phase of a group B, type III Streptococcus sp.

Authors:  A E Flores; P Ferrieri
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

7.  Novel observation of hot-cold-hot hemolysis exhibited by group B streptococci.

Authors:  Norio Okazaki; Ro Osawa; Rieko Suzuki; Takayasu Nikkawa; Robert A Whiley
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  Purification and characterization of salmolysin, an extracellular hemolytic toxin from Aeromonas salmonicida.

Authors:  S Nomura; M Fujino; M Yamakawa; E Kawahara
Journal:  J Bacteriol       Date:  1988-08       Impact factor: 3.490

9.  Partial characterization of Streptococcus suis type 2 hemolysin.

Authors:  I Feder; M M Chengappa; B Fenwick; M Rider; J Staats
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  In vivo hemolytic activity of group B streptococcus is dependent on erythrocyte-bacteria contact and independent of a carrier molecule.

Authors:  M W Platt
Journal:  Curr Microbiol       Date:  1995-07       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.